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Transcatheter aortic valve implantation (TAVI) is maturing strongly as an alternative to
surgical aortic valve replacement (SAVR) in patients who are inoperable/high risk for open
heart surgery. General anesthesia (GA) is the usual mode of anesthesia in these patients,
but local anesthesia with conscious sedation (LACS) has recently been described as a safe
alternative with some added advantages. We report 2 cases who were unfit for GA and
were done successfully under LACS.
Copyright ª 2014, Cardiological Society of India. All rights reserved.1. Introduction
Surgical aortic valve replacement (SAVR) is currently the
standard of care to treat patients with severe symptomatic
aortic stenosis (AS) and is generally accepted to alleviate
symptoms and prolong survival. Based on the results of ran-
domized trials, transcatheter aortic valve implantation (TAVI)
is the new standard of care for patients with symptomatic AS
who are deemed ‘inoperable’. Debatably, TAVI is also an
alternative to SAVR in selected patients who are at high risk
but operable.1 The technique of TAVI is thought to be reaching
maturity, although several clinical problems associated with
the treatment of such high-risk patients remain, with the
anesthetic management during TAVI being controversial.2
Soon after the introduction of TAVI, general anesthesia (GA)
with endotracheal intubation was usually chosen, despite
differences in the approach site used for this procedure.3e7
Recently, a few studies have demonstrated the feasibility ofom (S. Maqbool).
ciety of India. All rightsTAVI with the patient under local anesthesia with conscious
sedation (LACS), owing to the increased experience of the
technique and improved devices.8e10 GA ensures patient sta-
bility during TAVI, is more comfortable for the operator, and
facilitates the management of procedural complications and
the use of transesophageal echocardiography. The many
possible disadvantages of GA compared to LACS, include a
requirement for tracheal intubation and mechanical ventila-
tion, delayed extubation, hemodynamic instability, a lack of
continuous neurologic monitoring, and prolonged intensive
care unit and hospital stays. The LACS has the advantages of
being less invasive, shorter procedure time, shorter intensive
care unit stay, earlier recovery, shorter hospital stay and a
significant reduction in labor costs than the GA group.2 GA
also may not be feasible for patients with unsuitable airways
and severe respiratory comorbidities. We hereby present the
first Indian experience of TAVI under LACS in patients un-
suitable for GA.reserved.
i n d i a n h e a r t j o u rn a l 6 6 ( 2 0 1 4 ) 2 0 8e2 1 0 209We hereby present the first Indian experience of two pa-
tients who underwent TAVI under LACS as they were un-
suitable for GA.2. Case I
A 79-year old gentleman deemed unsuitable for SAVR was
evaluated for TAVI at our institute. His Euroscore was 36.
Duringpre-procedure evaluation theCTaortographyshoweda
superior mediastinal mass. This mass was large and com-
pressing the trachea significantly. The anaesthetist was of the
opinion that it would be difficult to intubate the patient in view
ofmore than 50%narrowingof the trachea by the thyroidmass
which was pressing it from posterior aspect. In view of the
benign nature of the thyroid mass, its removal was deferred.
TAVI was performed successfully under LACS with inj xylo-
caine locally, inj midazolam 0.05 mg/kg and fentanyl I mgm/kg
IV bolus followed by a target controlled infusion of propofol 10
to 75 mg/kg/min adjusted according to the response.3. Case II
The second case was a 79-year old gentleman at very high
risk for SAVR with a Euroscore of 40. He was a known case of
chronic bronchial asthma. He was planned for TAVI under
general anaesthesia but developed acute severe asthma in
hospital one day before the procedure. Asthmatic episode
was managed and plan was changed from general anaes-
thesia to local anesthesia with conscious sadation. Conscious
sedation was done similar to Case-I with inj xylocaine locally,
inj midazolam 0.05 mg/kg and fentanyl I mgm/kg IV bolus
followed by a target controlled infusion of propofol 10 to 75
mg/kg/min adjusted according to the response. TAVI was
carried out successfully in 45 minutes. He remained stable
without any respiratory complications during and after
procedure.4. Discussion
About 30e40% of patients with severe aortic stenosis remain
unfit for SAVR due to significant comorbidities and advanced
medical condition and this cohort of patients is supposed to
increase, reflecting the aging population and improving
therapeutic options.11 Transcatheter aortic valve implanta-
tion (TAVI) has emerged as a novel alternative procedure that
enables catheter-based treatment in unsuitable/high-risk
surgical aortic valve replacement patients. The technique of
TAVI is improving rapidly, but the anaesthetic management
remains controversial.2 The aim of the anaesthesia remains
to provide less invasive anesthesia/anaelgesia without
compromising on the safety and comfort of the patient. From
the beginning of the procedure general anesthesia has been
the most common mode of anaesthetizing the patients for
TAVI. General anesthesia not only allays the anxiety in the
patients and operators mind but allows the use of intra
procedural transesophageal echo imaging. TEE helps in cor-
rect positioning of the valve; valve retrieval in case ofinappropriate placement; quick detection and easy handling
of an intra procedural complication like severe AR and
Hemopericardium. On the other hand GA is not free of the
risks in this frail elderly population with comorbidities, bad
lungs, poor renal clearance and risks of procedure or anaes-
thesia related cerebral ischaemia. GA increases procedure
time, ICU/hospital stay, labor costs and may not be feasible
for patients unsuitable for endotracheal intubation and se-
vere respiratory illness.11 LACS is less invasive, reduces pro-
cedural time, decreases ICU/hospital stay and labor costs,
however there may be a failure rate of about 4e11% leading
to conversion of LACS to GA. The causes for failure like car-
diac arrest, myocardial infarction, cardiac temponade, stroke,
shock after balloon valvuloplasty and requirement of a high
access retroperitoneal approach are procedure related and
unrelated to the anesthetic approach.2 One of our patients
had a superior mediastinal mass and the other chronic se-
vere bronchial asthma, both deemed relatively unsuitable for
GA by the anesthesia team. The procedures were carried out
under LACS successfully in just 45 minutes in both the pa-
tients. Both were shifted to monitored rooms in one day and
discharged on day 5.5. Conclusion
Local anesthesia with conscious sedation may be an effective
alternative to general anesthesia for TAVI in general and
particularly in patients unsuitable for endotracheal intubation
and severe respiratory comorbidities.Conflicts of interest
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